| Study of the antidyskinetic effect of eltoprazine in animal models of levodopa‐induced dyskinesia E Bezard, E Tronci, EY Pioli, Q Li, G Porras, A Björklund, M Carta Movement Disorders 28 (8), 1088-1096, 2013 | 159 | 2013 |
| RGS9–2 negatively modulates L-3, 4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease SJ Gold, CV Hoang, BW Potts, G Porras, E Pioli, KW Kim, A Nadjar, C Qin, ... Journal of Neuroscience 27 (52), 14338-14348, 2007 | 141 | 2007 |
| Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for “NMDA antagonist modelling” of schizophrenia G Gilmour, EY Pioli, SL Dix, JW Smith, MW Conway, WT Jones, S Loomis, ... Psychopharmacology 205, 203-216, 2009 | 98 | 2009 |
| Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in rats EY Pioli, W Meissner, R Sohr, CE Gross, E Bezard, BH Bioulac Neuroscience 153 (4), 1213-1224, 2008 | 88 | 2008 |
| The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model E Bezard, EY Pioli, Q Li, F Girard, V Mutel, C Keywood, F Tison, O Rascol, ... Movement Disorders 29 (8), 1074-1079, 2014 | 82 | 2014 |
| Animal models of l-DOPA–induced dyskinesia: an update on the current options H Iderberg, V Francardo, EY Pioli Neuroscience 211, 13-27, 2012 | 75 | 2012 |
| An m G lu4‐P ositive A llosteric M odulator A lleviates P arkinsonism in P rimates D Charvin, T Di Paolo, E Bezard, L Gregoire, A Takano, G Duvey, E Pioli, ... Movement Disorders 33 (10), 1619-1631, 2018 | 62 | 2018 |
| An automated maze task for assessing hippocampus-sensitive memory in mice EY Pioli, BN Gaskill, G Gilmour, MD Tricklebank, SL Dix, D Bannerman, ... Behavioural brain research 261, 249-257, 2014 | 59 | 2014 |
| An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-treated macaque models WKD Ko, SM Camus, Q Li, J Yang, S McGuire, EY Pioli, E Bezard Neuropharmacology 110, 48-58, 2016 | 58 | 2016 |
| Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia E Bézard, A Munoz, E Tronci, EY Pioli, Q Li, G Porras, A Björklund, ... Neuroscience research 77 (4), 242-246, 2013 | 58 | 2013 |
| Why bother using non-human primate models of cognitive disorders in translational research? S Camus, WKD Ko, E Pioli, E Bezard Neurobiology of Learning and Memory 124, 123-129, 2015 | 55 | 2015 |
| Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine (MPTP)‐lesioned primate model of … WKD Ko, E Pioli, Q Li, S McGuire, A Dufour, TB Sherer, E Bezard, ... Movement Disorders 29 (6), 772-779, 2014 | 50 | 2014 |
| Levodopa improves motor deficits but can further disrupt cognition in a macaque Parkinson model JS Schneider, EY Pioli, Y Jianzhong, Q Li, E Bezard Movement Disorders 28 (5), 663-667, 2013 | 41 | 2013 |
| µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease E Bezard, Q Li, H Hulme, E Fridjonsdottir, A Nilsson, E Pioli, PE Andren, ... Journal of Neuroscience 40 (35), 6812-6819, 2020 | 28 | 2020 |
| Vector-mediated l-3,4-dihydroxyphenylalanine delivery reverses motor impairments in a primate model of Parkinson’s disease C Rosenblad, Q Li, EY Pioli, S Dovero, ASLM Antunes, L Agúndez, ... Brain 142 (8), 2402-2416, 2019 | 25 | 2019 |
| Effects of memantine and galantamine on cognitive performance in aged rhesus macaques JS Schneider, EY Pioli, Y Jianzhong, Q Li, E Bezard Neurobiology of Aging 34 (4), 1126-1132, 2013 | 20 | 2013 |
| Intraventricular dopamine infusion alleviates motor symptoms in a primate model of Parkinson's disease C Moreau, AS Rolland, E Pioli, Q Li, P Odou, C Barthelemy, D Lannoy, ... Neurobiology of Disease 139, 104846, 2020 | 19 | 2020 |
| Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonism J Baufreton, T Milekovic, Q Li, S McGuire, EM Moraud, G Porras, S Sun, ... Movement Disorders 33 (10), 1632-1642, 2018 | 18 | 2018 |
| Engrailed‐1 induces long‐lasting behavior benefit in an experimental Parkinson primate model N Thomasson, E Pioli, C Friedel, A Monseur, J Lavaur, KL Moya, ... Movement Disorders 34 (7), 1082-1084, 2019 | 14 | 2019 |
| Meta‐analysis of amantadine efficacy for improving preclinical research reliability P Stanley, EY Pioli, R Kozak, M Popiolek, E Bezard Movement Disorders 33 (10), 1555-1557, 2018 | 12 | 2018 |
